Antibodies

14 Jan 2008 FDA Approves TYSABRI(R) For The Treatment Of Moderate-To-Severe Crohn's Disease
09 Jan 2008 TRACON Pharmaceuticals Announces Dosing of Initial Three Cancer Patients in a Phase 1 Clinical Trial with TRC105, a Human Chimeric Antibody
09 Jan 2008 Anthera Pharmaceuticals Acquires the Worldwide Rights to a BAFF Inhibitor for the Treatment of Lupus and Other Autoimmune Diseases
09 Jan 2008 Medarex Announces Allowance of Investigational New Drug Application for Wholly Owned Fully Human Anti-CD70 Antibody, MDX-1411
08 Jan 2008 Biogen Idec and PDL BioPharma License the Rights to Develop Volociximab in Ophthalmic Indications to Ophthotech
07 Jan 2008 Seattle Genetics Earns Milestone Payment from Initiation of SGN-40 Phase Ib Clinical Trial in Combination with Rituxan for Non-Hodgkin Lymphoma
04 Jan 2008 Genmab Announces HuMax-CD32B Pre-Clinical Program
03 Jan 2008 Crucell Enters Agreement with Sanofi Pasteur for Next-generation Biologicals against Rabies
03 Jan 2008 ImmunoGen, Inc. Expands Pipeline of Targeted Anticancer Compounds
03 Jan 2008 Expanded Labeling for MabCampath(R) in Europe
30 Dec 2007 MorphoSys Files Clinical Trial Application to Initiate First Phase 1 Clinical Study of its MOR103 Program
22 Dec 2007 Elan and Wyeth Dose First Patient in North America in Phase 3 Program for Bapineuzumab (AAB-001) in Alzheimer's Disease
21 Dec 2007 Centocor, Schering-Plough Revise Agreement Covering REMICADE, Golimumab
21 Dec 2007 Fresenius Biotech applies for the marketing authorization of the trifunctional antibody Removab (R) for the treatment of malignant ascites
21 Dec 2007 Ablinx Extends Agreement With Wyeth
20 Dec 2007 Human Genome Sciences initiates second randomized Phase 2 trial of HGS- ETR 1 in combination with chemotherapy
20 Dec 2007 R1507 antibody to enter Phase II study to treat sarcoma
20 Dec 2007 Abbott's HUMIRA (R) Approved in the European Union for Treatment of Moderate-to-Severe Plaque Psoriasis
19 Dec 2007 Avastin approved in Europe for first-line treatment of patients with advanced kidney cancer
17 Dec 2007 Auxilium Pharmaceuticals, Inc. Completes Enrollment in Two Phase III Clinical Trials of XIAFLEX(TM) for Dupuytren's Contracture
17 Dec 2007 Ablynx Reports Positive Phase I Results for Its Anti-Thrombotic Nanobody(R), ALX-0081
14 Dec 2007 Pivotal Phase 3 Data Show Denosumab Increased Bone Density Throughout Skeleton in Non-Metastatic Breast Cancer Patients on Adjuvant Aromatase Inhibitor Therapy
14 Dec 2007 WILEX announces positive result of the interim analysis for futility of its Phase III ARISER trial with RENCAREX(R)
13 Dec 2007 Merck Announces Initiation of Phase II/III Clinical Trial of Atacicept in Lupus Nephritis
13 Dec 2007 Genmab announces details of planned Ofatumumab Phase II study in multiple sclerosis

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top